We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DMAC market cap is 98.68M. The company's latest EPS is USD -0.3603 and P/E is -7.33.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 527k | 0 |
| Operating Income | -3.13M | -3.97M | -5.52M | -4.21M | -5.16M |
| Net Income | -3.06M | -3.75M | -5.27M | -4.48M | -4.47M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.71M | 0 | 0 | 0 | 0 |
| Operating Income | -5.55M | -11.59M | -12.7M | -13.65M | -14M |
| Net Income | -5.73M | -10.65M | -12.29M | -13.59M | -13.68M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 37.04M | 34.4M | 30.22M | 62.05M | 58.14M |
| Total Liabilities | 1.96M | 2.57M | 3.2M | 2.31M | 2.51M |
| Total Equity | 35.08M | 31.83M | 27.02M | 59.74M | 55.63M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.34M | 9.05M | 28.1M | 45.55M | 34.4M |
| Total Liabilities | 1.31M | 1.44M | 2.08M | 1.53M | 2.57M |
| Total Equity | 17.03M | 7.62M | 26.01M | 44.02M | 31.83M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.75M | -11.51M | -5.09M | -10.12M | -14.92M |
| Investing | 6.81M | 11.54M | 2.51M | -25.62M | -24.42M |
| Financing | -5k | -6k | -1,000 | 36.85M | 36.84M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.7M | -9.1M | -9.19M | -12.25M | -11.51M |
| Investing | -50k | -3.91M | -16.13M | -20.54M | 11.54M |
| Financing | 21.22M | 70k | 28.85M | 30.09M | -6k |
| Market Cap | 98.68M |
| Price to Earnings Ratio | -7.33 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 21.19 |
| Price to Book Ratio | 3.15 |
| Dividend Yield | - |
| Shares Outstanding | 37.95M |
| Average Volume (1 week) | 19.55k |
| Average Volume (1 Month) | 16.24k |
| 52 Week Change | -17.20% |
| 52 Week High | 4.75 |
| 52 Week Low | 1.9382 |
| Spread (Intraday) | 1.1 (31.88%) |
| Company Name | DiaMedica Therapeutics Inc |
| Address |
301 carlson parkway, suite 210 minneapolis, minnesota 55305 |
| Website | https://www.diamedica.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
